What is Rewrite Tomorrow?
Rewrite Tomorrow is a support website for people with advancing Parkinson’s disease (PD)
The site is aimed at:
- helping you make appropriate lifestyle and disease management choices
- assisting communication between people with Parkinson's, their healthcare team, and their family and friends
Who is Rewrite Tomorrow for?
- Primarily, for people with Parkinson's when quality of life is significantly impaired despite optimal pharmacological treatment
- More generally all people with Parkinson's disease
- Relatives, friends and colleagues of people with Parkinson's
- Healthcare professionals caring for people with Parkinson's
When should Rewrite Tomorrow be used?
- At any stage of Parknson's, and particularly when your independence, social, professional, physical or emotional states are affected
- When preparing for consultations with your healthcare team
- To review your options for treatment and coping with Parkinson's as it progresses
Why use Rewrite Tomorrow?
- All information is in one place – saves time
- To play an active role in your treatment plan
- To make the most of all available opportunities to make a difference in your daily life
- To help you communicate more effectively with your healthcare team
How can I contribute to Rewrite Tomorrow?
- Submitting your own tips can help improve others’ daily living
- Sharing your personal experiences and how you manage Parkinson's serves as an example to others
If you would like to contribute to the website, email us at rewriteTomorrow@epda.eu.com and we will get back to you as soon as we can.
Who is behind Rewrite Tomorrow?
Rewrite Tomorrow has been developed by the European Parkinson's Disease Association [EPDA] with the support of Medtronic involving the expertise of a multidisciplinary team of leading healthcare professionals in the field of Parkinson's disease.
Editorial
| Liz Butler-Graham |
|
| Lizzie Graham |
|
| Mariella Graziano |
|
| Carolyn Loveless |
- Co-ordinator & researcher
|
| Chiu Keung Man |
- Website design & development
|
EPDA Medical Advisory Board
See EPDA website
